Business Description
K Pharma Inc
ISIN : JP3280900006
Total Employee Number:
20Description
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.44 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 2.12 | |||||
Debt-to-EBITDA | -1.6 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -30.9 | |||||
3-Year EPS without NRI Growth Rate | -27 | |||||
3-Year FCF Growth Rate | -23.8 | |||||
3-Year Book Growth Rate | -1.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.67 | |||||
9-Day RSI | 58.54 | |||||
14-Day RSI | 57.99 | |||||
3-1 Month Momentum % | 5.11 | |||||
6-1 Month Momentum % | -17.59 | |||||
12-1 Month Momentum % | 11.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 18.65 | |||||
Quick Ratio | 18.59 | |||||
Cash Ratio | 17.59 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -80.78 | |||||
ROA % | -43.54 | |||||
ROIC % | -648.48 | |||||
3-Year ROIIC % | -584.59 | |||||
ROC (Joel Greenblatt) % | -1590.04 | |||||
ROCE % | -44.72 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 11.64 | |||||
Price-to-Tangible-Book | 11.64 | |||||
EV-to-EBIT | -7.94 | |||||
EV-to-EBITDA | -7.94 | |||||
EV-to-FCF | -9.04 | |||||
| Price-to-Net-Current-Asset-Value | 12.65 | |||||
| Price-to-Net-Cash | 15.8 | |||||
Earnings Yield (Greenblatt) % | -12.59 | |||||
FCF Yield % | -10.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
K Pharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -89.67 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 39.37 | ||
| 14-Day RSI | 57.99 | ||
| 14-Day ATR (円) | 23.293645 | ||
| 20-Day SMA (円) | 753.75 | ||
| 12-1 Month Momentum % | 11.11 | ||
| 52-Week Range (円) | 604 - 949 | ||
| Shares Outstanding (Mil) | 11.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
K Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
K Pharma Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
K Pharma Inc Frequently Asked Questions
What is K Pharma Inc(TSE:4896)'s stock price today?
The current price of TSE:4896 is 円775.00. The 52 week high of TSE:4896 is 円949.00 and 52 week low is 円604.00.
When is next earnings date of K Pharma Inc(TSE:4896)?
The next earnings date of K Pharma Inc(TSE:4896) is .
Does K Pharma Inc(TSE:4896) pay dividends? If so, how much?
K Pharma Inc(TSE:4896) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on K Pharma Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers